{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:54:36Z","timestamp":1775188476182,"version":"3.50.1"},"reference-count":177,"publisher":"Elsevier","isbn-type":[{"value":"9780323950572","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008480","name":"Arkansas Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK126452"],"award-info":[{"award-number":["DK126452"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.apha.2023.01.001","type":"book-chapter","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:24:44Z","timestamp":1683707084000},"page":"1-35","source":"Crossref","is-referenced-by-count":4,"title":["Bioactive lipids in hypertension"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apha.2023.01.001_bb0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/HJH.0000000000003038","article-title":"Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase","volume":"40","author":"Agostinucci","year":"2022","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.31.1.232","article-title":"Induction of P4504A activity improves pressure-natriuresis in dahl S rats","volume":"31","author":"Alonso-Galicia","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cardiores.2006.09.013","article-title":"Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid","volume":"73","author":"Ander","year":"2007","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0002-9440(10)62287-0","article-title":"Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12\/15-lipoxygenase knockout mice","volume":"166","author":"Anning","year":"2005","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.plefa.2016.03.004","article-title":"Specialised pro-resolving mediators of inflammation in inflammatory arthritis","volume":"107","author":"Barden","year":"2016","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/bs.apha.2023.01.001_bb0035","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/HYPERTENSIONAHA.112.199026","article-title":"EP1 disruption attenuates end-organ damage in a mouse model of hypertension","volume":"60","author":"Bartlett","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0040","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","article-title":"Epoxyeicosatrienoic acid pathway in human health and diseases","volume":"61","author":"Bellien","year":"2013","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0050","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/bph.15336","article-title":"Omega-3 polyunsaturated fatty acids and hypertension: A review of vasodilatory mechanisms of docosahexaenoic acid and eicosapentaenoic acid","volume":"178","author":"Bercea","year":"2021","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0055","first-page":"37","article-title":"Comparative aspects of omega-3 and omega-6 polyunsaturated fatty acids in rabbits and rats: Effects on platelet function, thromboxane and prostacyclin generation, tissue phospholipid fatty acids and membrane fluidity","volume":"31","author":"Bolton-Smith","year":"1984","journal-title":"British Journal of Clinical Practice. Supplement"},{"key":"10.1016\/bs.apha.2023.01.001_bb0060","doi-asserted-by":"crossref","first-page":"H1656","DOI":"10.1152\/ajpheart.00597.2001","article-title":"14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(ca) channels","volume":"282","author":"Campbell","year":"2002","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.ki.5002394","article-title":"Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension","volume":"72","author":"Capdevila","year":"2007","journal-title":"Kidney International"},{"key":"10.1016\/bs.apha.2023.01.001_bb0070","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1074\/jbc.M113.508416","article-title":"Imig JD, Harris RC, Wang W. the Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt","volume":"289","author":"Capdevila","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.01.001_bb903","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/med.21251","article-title":"Eicosanoids and their drugs in cardiovascular diseases: Focus on atherosclerosis and stroke","volume":"33","author":"Capra","year":"2013","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/bs.apha.2023.01.001_bb0075","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1073\/pnas.1402965111","article-title":"Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase","volume":"111","author":"Charles","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.apha.2023.01.001_bb0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/CS20200128","article-title":"Short-chain fatty acid, acylation and cardiovascular diseases","volume":"134","author":"Chen","year":"2020","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2023.01.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.90253.2008","article-title":"Increased dietary NaCl induces renal medullary PGE2 production and natriuresis via the EP2 receptor","volume":"295","author":"Chen","year":"2008","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.HYP.0000116221.27079.ea","article-title":"Cyclooxygenases, the kidney, and hypertension","volume":"43","author":"Cheng","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/157016109788340659","article-title":"Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management","volume":"7","author":"Cicero","year":"2009","journal-title":"Current Vascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.numecd.2016.07.011","article-title":"Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes","volume":"27","author":"Colussi","year":"2017","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"key":"10.1016\/bs.apha.2023.01.001_bb893","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/1028415X.2017.1327685","article-title":"Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians","volume":"21","author":"Cribb","year":"2018","journal-title":"Nutritional Neuroscience"},{"key":"10.1016\/bs.apha.2023.01.001_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2018.01.002","article-title":"Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review","volume":"11","author":"Das","year":"2018","journal-title":"Journal of Advanced Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107418","article-title":"Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions","volume":"205","author":"Davies","year":"2020","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/HYPERTENSIONAHA.122.19448","article-title":"Resolvin D2 attenuates cardiovascular damage in angiotensin II-induced hypertension","volume":"80","author":"D\u00edaz Del Campo","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb898","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10753-016-0448-6","article-title":"Soluble epoxide hydrolase inhibitor suppresses the expression of triggering receptor expressed on myeloid Cells-1 by inhibiting NF-kB activation in murine macrophage","volume":"40","author":"Dikalova","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.plipres.2010.10.005","article-title":"Functional and pathological roles of the 12- and 15-lipoxygenases","volume":"50","author":"Dobrian","year":"2011","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb904","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2017.07.002","article-title":"Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38\/Smad3 pathways","volume":"389","author":"Dong","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0125","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1152\/ajpregu.00713.2003","article-title":"Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis","volume":"287","author":"Dos Santos","year":"2004","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/HCO.0b013e3283474c20","article-title":"Is blood pressure control to less than 140\/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: Or is this as good as it gets?","volume":"26","author":"Egan","year":"2011","journal-title":"Current Opinion in Cardiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/HYPERTENSIONAHA.121.16495","article-title":"Immune mechanisms of dietary salt-induced hypertension and kidney disease: Harry Goldblatt award for early career investigators 2020","volume":"78","author":"Elijovich","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0140","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1152\/ajpregu.00466.2007","article-title":"TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats","volume":"294","author":"Elmarakby","year":"2008","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.107.098806","article-title":"Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension","volume":"50","author":"Elmarakby","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0150","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.34067\/KID.0001272022","article-title":"Dendritic cell epithelial Sodium Channel in inflammation, salt-sensitive hypertension, and kidney damage","volume":"3","author":"Ertuglu","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/bs.apha.2023.01.001_bb0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2741\/4465","article-title":"Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology","volume":"21","author":"Fan","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/bs.apha.2023.01.001_bb0160","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1681\/ASN.2017030252","article-title":"Effect of cytochrome P450 metabolites of arachidonic acid in nephrology","volume":"28","author":"Fan","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/bs.apha.2023.01.001_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113749","article-title":"Intake of omega-3 formulation EPA:DHA 6:1 by old rats for 2 weeks improved endothelium-dependent relaxations and normalized the expression level of ACE\/AT1R\/NADPH oxidase and the formation of ROS in the mesenteric artery","volume":"173","author":"Farooq","year":"2020","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0170","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00424-010-0812-6","article-title":"Vasoconstrictor prostanoids","volume":"459","author":"F\u00e9l\u00e9tou","year":"2010","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/bs.apha.2023.01.001_bb0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.HYP.0000112225.27560.24","article-title":"Role for thromboxane receptors in angiotensin-II-induced hypertension","volume":"43","author":"Francois","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb891","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1573403X14666180222102312","article-title":"Management of measurable variable cardiovascular disease\u2019 risk factors","volume":"14","author":"Francula-Zaninovic","year":"2018","journal-title":"Current Cardiology Reviews"},{"key":"10.1016\/bs.apha.2023.01.001_bb0180","first-page":"F816","article-title":"12-HETE modulates Na-coupled uptakes in proximal tubular cells: Role of diacylglycerol kinase inhibition","volume":"259","author":"Friedlander","year":"1990","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2022.02.003","article-title":"The CYP\/20-HETE\/GPR75 axis in hypertension","volume":"94","author":"Froogh","year":"2022","journal-title":"Advances in Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.0000151309.82473.59","article-title":"Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension","volume":"111","author":"Gainer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0195","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein-coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0200","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1152\/ajpregu.00039.2015","article-title":"Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension","volume":"309","author":"Garcia","year":"2015","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.115.229377","article-title":"20-HETE activates the transcription of angiotensin-converting enzyme via nuclear factor-\u03baB translocation and promoter binding","volume":"356","author":"Garcia","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0210","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cts.12672","article-title":"Pharmacokinetic and pharmacodynamic effects of Oral CXA-10, a nitro fatty acid, after single and multiple ascending doses in healthy and obese subjects","volume":"12","author":"Garner","year":"2019","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/bs.apha.2023.01.001_bb0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/gtmb.2018.0202","article-title":"Association between the CYP4F2 gene rs1558139 and rs2108622 polymorphisms and hypertension: A Meta-analysis","volume":"23","author":"Geng","year":"2019","journal-title":"Genetic Testing and Molecular Biomarkers"},{"key":"10.1016\/bs.apha.2023.01.001_bb894","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1152\/japplphysiol.90785.2008","article-title":"Cyclooxygenase and thromboxane\/prostaglandin receptor contribute to aortic endothelium-dependent dysfunction in aging female spontaneously hypertensive rats","volume":"107","author":"Graham","year":"2009","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0220","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tips.2017.05.008","article-title":"The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs","volume":"38","author":"Grosser","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.apha.2023.01.001_bb0225","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1172\/JCI29838","article-title":"Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting","volume":"117","author":"Guan","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0230","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000025915","article-title":"Leukotriene D4 inhibits Na+ uptake through cAMP and PLC pathways in primary cultured renal proximal tubular cells","volume":"22","author":"Han","year":"1999","journal-title":"Kidney & Blood Pressure Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0235","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCRESAHA.121.318082","article-title":"Pathophysiology of hypertension: The mosaic theory and beyond","volume":"128","author":"Harrison","year":"2021","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-6980(87)90014-1","article-title":"Interaction between prostaglandin E2 and leukotriene D4 on the excretion of electrolytes by the dog kidney in vivo","volume":"33","author":"H\u00e9bert","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/bs.apha.2023.01.001_bb0245","first-page":"518","article-title":"Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the rat","volume":"14","author":"Hui","year":"1991","journal-title":"Clinical and Investigative Medicine"},{"key":"10.1016\/bs.apha.2023.01.001_bb0250","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/CS20130479","article-title":"Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition","volume":"127","author":"Hye Khan","year":"2014","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2023.01.001_bb0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/CS20050251","article-title":"Eicosanoids and renal vascular function in diseases","volume":"111","author":"Imig","year":"2006","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2023.01.001_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.06.015","article-title":"Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics","volume":"192","author":"Imig","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0265","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1042\/CS20191209","article-title":"Eicosanoid blood vessel regulation in physiological and pathological states","volume":"134","author":"Imig","year":"2020","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2023.01.001_bb900","doi-asserted-by":"crossref","first-page":"F415","DOI":"10.1152\/ajprenal.00351.2001","article-title":"Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice","volume":"283","author":"Imig","year":"2002","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10739680701456960","article-title":"Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+\u2212activated K+ channels","volume":"15","author":"Imig","year":"2008","journal-title":"Microcirculation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0275","first-page":"157","article-title":"Development of epoxyeicosatrienoic acid analogs with in vivo anti-hypertensive actions","volume":"1","author":"Imig","year":"2010","journal-title":"Frontiers in Vascular Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.120.13898","article-title":"Epoxy fatty acids: From salt regulation to kidney and cardiovascular therapeutics: 2019 Lewis K dahl memorial lecture","volume":"76","author":"Imig","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0285","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/j.2040-4603.2016.tb00678.x","article-title":"Cytochrome P450 and lipoxygenase metabolites on renal function","volume":"6","author":"Imig","year":"2015","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0290","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","article-title":"An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension","volume":"46","author":"Imig","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb902","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/01.HYP.33.1.419","article-title":"Role of 20-HETE in elevating chloride transport in the thick ascending limb of dahl SS\/Jr rats","volume":"33","author":"Ito","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0295","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/bph.14151","article-title":"Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619","volume":"175","author":"Jannaway","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0300","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/HYPERTENSIONAHA.108.111229","article-title":"Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress","volume":"52","author":"Jia","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0305","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.RES.0000251306.40546.08","article-title":"Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion","volume":"99","author":"Jia","year":"2006","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb901","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.HYP.0000029240.44253.5E","article-title":"P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage","volume":"40","author":"Kaergel","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0310","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/5583","article-title":"Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor","volume":"5","author":"Kennedy","year":"1999","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2023.01.001_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-801238-3.96704-7","article-title":"Antihypertensive drugs","author":"Khan","year":"2018","journal-title":"Reference Module in Biomedical Sciences"},{"key":"10.1016\/bs.apha.2023.01.001_bb0320","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.3390\/ijms222112029","article-title":"Effects of arachidonic acid metabolites on cardiovascular health and disease","volume":"22","author":"Khan","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apha.2023.01.001_bb0325","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/156802607779941314","article-title":"Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers","volume":"7","author":"Khanapure","year":"2007","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2023.01.001_bb897","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2009.10.046","article-title":"Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids","volume":"48","author":"Khoo","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/bs.apha.2023.01.001_bb0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/hr.2012.119","article-title":"Comparison of 12-lipoxygenase expression in vascular smooth muscle cells from old normotensive Wistar-Kyoto rats with spontaneously hypertensive rats","volume":"36","author":"Kim","year":"2013","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01213011-200501000-00002","article-title":"Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension","volume":"15","author":"King","year":"2005","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0340","doi-asserted-by":"crossref","first-page":"F1435","DOI":"10.1152\/ajprenal.00176.2006","article-title":"Role of 20-HETE in D1\/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule","volume":"292","author":"Kirchheimer","year":"2007","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0345","doi-asserted-by":"crossref","first-page":"E691","DOI":"10.1152\/ajpendo.00710.2010","article-title":"Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats","volume":"300","author":"Koeners","year":"2011","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/bs.apha.2023.01.001_bb0350","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1161\/HYPERTENSIONAHA.122.19305","article-title":"IsoLGs (Isolevuglandins) drive neutrophil migration in hypertension and are essential for the formation of neutrophil extracellular traps","volume":"79","author":"Krishnan","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0355","doi-asserted-by":"crossref","first-page":"H2428","DOI":"10.1152\/ajpheart.01120.2011","article-title":"Mice lacking macrophage 12\/15-lipoxygenase are resistant to experimental hypertension","volume":"302","author":"Kriska","year":"2012","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0360","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/HYPERTENSIONAHA.121.17824","article-title":"Macrophage 12(S)-HETE enhances angiotensin II-induced contraction by a BLT2 (leukotriene B4 Type-2 receptor) and TP (thromboxane receptor)-mediated mechanism in murine arteries","volume":"79","author":"Kriska","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0365","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jash.2014.04.011","article-title":"Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: An exploratory pilot study in African Americans","volume":"8","author":"Laffer","year":"2014","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102219","article-title":"Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation","volume":"164","author":"Lamon-Fava","year":"2021","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/bs.apha.2023.01.001_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107549","article-title":"5-Lypoxygenase products are involved in renal tubulointerstitial injury induced by albumin overload in proximal tubules in mice","volume":"9","author":"Landgraf","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.01.001_bb0380","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1096\/fj.10-160119","article-title":"Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice","volume":"24","author":"Lee","year":"2010","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2023.01.001_bb0385","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/HYPERTENSIONAHA.110.161695","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans","volume":"57","author":"Lee","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0390","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1039\/D0FO02890H","article-title":"Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43\/41 pathway","volume":"12","author":"Li","year":"2021","journal-title":"Food & Function"},{"key":"10.1016\/bs.apha.2023.01.001_bb0395","doi-asserted-by":"crossref","first-page":"F1696","DOI":"10.1152\/ajprenal.90502.2008","article-title":"Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in dahl salt-sensitive rats","volume":"295","author":"Liclican","year":"2008","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0400","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/HYPERTENSIONAHA.121.17809","article-title":"Resolvin E1 attenuates pulmonary hypertension by suppressing Wnt7a\/\u03b2-catenin signaling","volume":"78","author":"Liu","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0405","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1681\/ASN.2007060713","article-title":"Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension","volume":"19","author":"Liu","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/bs.apha.2023.01.001_bb895","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/CS20120483","article-title":"Role of the CYP4A\/20-HETE pathway in vascular dysfunction of the dahl salt-sensitive rat","volume":"124","author":"Lukaszewicz","year":"2013","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/bs.apha.2023.01.001_bb0410","doi-asserted-by":"crossref","first-page":"15133","DOI":"10.4238\/2015.November.25.1","article-title":"Association of the CYP4F2 rs2108622 genetic polymorphism with hypertension: A meta-analysis","volume":"14","author":"Luo","year":"2015","journal-title":"Genetics and Molecular Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0415","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00204-015-1620-8","article-title":"The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy","volume":"90","author":"Maayah","year":"2016","journal-title":"Archives of Toxicology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0420","doi-asserted-by":"crossref","first-page":"F740","DOI":"10.1152\/ajprenal.00098.2009","article-title":"Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension","volume":"297","author":"Manhiani","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0425","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/hep.23928","article-title":"Disruption of the 12\/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease","volume":"52","author":"Mart\u00ednez-Clemente","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0430","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clnu.2015.04.004","article-title":"A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease","volume":"35","author":"Mas","year":"2016","journal-title":"Clinical Nutrition"},{"key":"10.1016\/bs.apha.2023.01.001_bb0435","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1111\/bph.13205","article-title":"Constrictor prostanoids and uridine adenosine tetraphosphate: Vascular mediators and therapeutic targets in hypertension and diabetes","volume":"172","author":"Matsumoto","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0440","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0021-9150(98)00253-6","article-title":"Cholesterol and omega-3 fatty acids inhibit Na, K-ATPase activity in human endothelial cells","volume":"142","author":"Mayol","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.apha.2023.01.001_bb0445","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0895-7061(98)00256-8","article-title":"Cytochrome P-450 arachidonate metabolite inhibition improves renal function in Lyon hypertensive rats","volume":"12","author":"Messer-L\u00e9tienne","year":"1999","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0450","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41440-021-00804-0","article-title":"Role of the microbiota in hypertension and antihypertensive drug metabolism","volume":"45","author":"Mishima","year":"2022","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0455","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/bph.14167","article-title":"Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system","volume":"176","author":"Mitchell","year":"2019","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0460","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCRESAHA.119.314927","article-title":"Cell-specific gene deletion reveals the antithrombotic function of COX1 and explains the vascular COX1\/prostacyclin paradox","volume":"125","author":"Mitchell","year":"2019","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0465","doi-asserted-by":"crossref","first-page":"eabf6054","DOI":"10.1126\/sciadv.abf6054","article-title":"Endothelial cyclooxygenase-1 paradoxically drives local vasoconstriction and atherogenesis despite underpinning prostacyclin generation","volume":"7","author":"Mitchell","year":"2021","journal-title":"Science Advances"},{"key":"10.1016\/bs.apha.2023.01.001_bb0470","article-title":"Nitrated fatty acids in cardiovascular diseases","volume":"26","author":"Mollenhauer","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/bs.apha.2023.01.001_bb0475","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1172\/JCI27546","article-title":"Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel","volume":"116","author":"Nakagawa","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0480","first-page":"157","article-title":"Prostacyclin synthase gene: Genetic polymorphisms and prevention of some cardiovascular diseases","volume":"3","author":"Nakayama","year":"2005","journal-title":"Current Medicinal Chemistry. Cardiovascular and Hematological Agents"},{"key":"10.1016\/bs.apha.2023.01.001_bb899","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1681\/ASN.2015050528","article-title":"PGE2, Kidney disease, and cardiovascular risk: Beyond hypertension and diabetes","volume":"27","author":"Nasrallah","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0485","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41374-019-0317-7","article-title":"Prostaglandin E2 receptor EP1 (PGE2\/EP1) deletion promotes glomerular podocyte and endothelial cell injury in hypertensive TTRhRen mice","volume":"100","author":"Nasrallah","year":"2020","journal-title":"Laboratory Investigation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0490","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/hr.2017.72","article-title":"EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: Role of NADPH oxidase- and COX-derived oxidative stress","volume":"40","author":"Niazi","year":"2017","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0495","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/bs.apha.2023.01.001_bb0500","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI119279","article-title":"20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. role in regulation of rat renal Na+,K+-ATPase","volume":"99","author":"Nowicki","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0505","first-page":"H1774","article-title":"Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats","volume":"259","author":"Nozawa","year":"1990","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0510","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/sj.bjp.0704960","article-title":"20-Hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilar artery via PKC alpha-mediated inhibition of KCa channel","volume":"137","author":"Obara","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166241","article-title":"Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension","volume":"1867","author":"Olivares-Silva","year":"2021","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/bs.apha.2023.01.001_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2021.102377","article-title":"PUFA, genotypes and risk for cardiovascular disease","volume":"176","author":"Panda","year":"2022","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/bs.apha.2023.01.001_bb0525","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.122.320818","article-title":"DC ENaC-dependent inflammasome activation contributes to salt-sensitive hypertension","volume":"131","author":"Pitzer","year":"2022","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0530","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/10641963.2016.1246562","article-title":"The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population","volume":"39","author":"Polonikov","year":"2017","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0535","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacbts.2020.04.004","article-title":"Highly reactive Isolevuglandins promote atrial fibrillation caused by hypertension","volume":"5","author":"Prinsen","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/bs.apha.2023.01.001_bb0540","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.ki.5000147","article-title":"A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE","volume":"69","author":"Quintana","year":"2006","journal-title":"Kidney International"},{"key":"10.1016\/bs.apha.2023.01.001_bb0545","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fphys.2020.00277","article-title":"Protective effects of short-chain fatty acids on endothelial dysfunction induced by angiotensin II","volume":"11","author":"Robles-Vera","year":"2020","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0550","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ajh\/hpaa103","article-title":"Microbiota and hypertension: Role of the sympathetic nervous system and the immune system","volume":"33","author":"Robles-Vera","year":"2020","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0555","doi-asserted-by":"crossref","first-page":"F1463","DOI":"10.1152\/ajprenal.00360.2005","article-title":"Characterization of blood pressure and renal function in chromosome 5 congenic strains of dahl S rats","volume":"290","author":"Roman","year":"2006","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0560","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/01.HYP.21.6.985","article-title":"Clofibrate prevents the development of hypertension in dahl salt-sensitive rats","volume":"121","author":"Roman","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0565","doi-asserted-by":"crossref","first-page":"231","DOI":"10.23736\/S2724-5683.21.05538-9","article-title":"Cardiovascular disease burden: Italian and global perspectives","volume":"69","author":"Saglietto","year":"2021","journal-title":"Minerva Cardiol Angiol"},{"key":"10.1016\/bs.apha.2023.01.001_bb0570","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3945\/ajcn.111.018036","article-title":"Effect of low doses of long-chain n-3 PUFAs on endothelial function and arterial stiffness: A randomized controlled trial","volume":"94","author":"Sanders","year":"2011","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/bs.apha.2023.01.001_bb0575","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.plefa.2007.04.004","article-title":"Association between prostaglandin E2 receptor gene and essential hypertension","volume":"77","author":"Sato","year":"2007","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/bs.apha.2023.01.001_bb0580","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.niox.2018.06.006","article-title":"Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases","volume":"79","author":"Schopfer","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/bs.apha.2023.01.001_bb0585","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2017.10.016","article-title":"Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases","volume":"183","author":"Schunck","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0590","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: Emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0595","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3390\/biom10081127","article-title":"The short overview on the relevance of fatty acids for human cardiovascular disorders","volume":"10","author":"Shramko","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/bs.apha.2023.01.001_bb0600","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000513886","article-title":"Genetic variation, diet, inflammation, and the risk for COVID-19","volume":"14","author":"Simopoulos","year":"2021","journal-title":"Lifestyle Genom"},{"key":"10.1016\/bs.apha.2023.01.001_bb0605","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plipres.2018.11.001","article-title":"Emerging role of 12\/15-lipoxygenase (ALOX15) in human pathologies","volume":"73","author":"Singh","year":"2019","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0610","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.0000143832.91812.60","article-title":"Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2","volume":"110","author":"Spiecker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.apha.2023.01.001_bb0615","first-page":"151","article-title":"Leucotri\u00e8nes et 12-HETE: Modulateurs des effets vasculaires de l'angiotensine II. Implication dans l'hypertension art\u00e9rielle [leukotrienes and 12-HETE: Key mediators of angiotensin II-mediated vascular effects. Rol in hypertension]","volume":"57","author":"Stanke-Labesque","year":"2002","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/bs.apha.2023.01.001_bb0620","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1152\/physiolgenomics.00003.2007","article-title":"Functional polymorphism in human CYP4F2 decreases 20-HETE production","volume":"30","author":"Stec","year":"2007","journal-title":"Physiological Genomics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0625","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.HYP.33.1.414","article-title":"Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles","volume":"33","author":"Sun","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0630","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.prostaglandins.2011.07.001","article-title":"Prostaglandin E2 modulation of blood pressure homeostasis: Studies in rodent models","volume":"96","author":"Swan","year":"2011","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.001_bb0635","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.HYP.31.3.866","article-title":"Prostaglandin I2 contributes to the vasodepressor effect of baicalein in hypertensive rats","volume":"31","author":"Takizawa","year":"1998","journal-title":"Hypertension"},{"issue":"Sep 8","key":"10.1016\/bs.apha.2023.01.001_bb0640","article-title":"Epidemiology of cardiovascular disease in Europe","author":"Townsend","year":"2021","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0645","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FJC.0000000000000094","article-title":"An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension","volume":"64","author":"Ulu","year":"2014","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0650","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41371-021-00627-z","article-title":"Innate immunity and clinical hypertension","volume":"36","author":"Van Beusecum","year":"2022","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0655","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/HJH.0000000000000131","article-title":"Dietary fish oil improves endothelial function and lowers blood pressure via suppression of sphingolipid-mediated contractions in spontaneously hypertensive rats","volume":"32","author":"van den Elsen","year":"2014","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0660","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2741\/4425","article-title":"Nitro-fatty acids in cardiovascular regulation and diseases: Characteristics and molecular mechanisms","volume":"21","author":"Villacorta","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/bs.apha.2023.01.001_bb0665","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1124\/jpet.104.077644","article-title":"Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: Role of inducible nitric-oxide synthase and oxidative stress","volume":"312","author":"Virdis","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0670","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/HYPERTENSIONAHA.114.03654","article-title":"Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla","volume":"64","author":"Wang","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/bs.apha.2023.01.001_bb0675","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.00112.2020","article-title":"COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats","volume":"319","author":"Wang","year":"2020","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0680","doi-asserted-by":"crossref","first-page":"F453","DOI":"10.1152\/ajprenal.00123.2014","article-title":"Cyp2c44 epoxygenase in the collecting duct is essential for the high K+ intake-induced antihypertensive effect","volume":"307","author":"Wang","year":"2014","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0685","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/HJH.0000000000002473","article-title":"Association of plasma cyclooxygenase-2 levels and genetic polymorphisms with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adults","volume":"38","author":"Wang","year":"2020","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0690","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/HYPERTENSIONAHA.107.104463","article-title":"A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure","volume":"51","author":"Ward","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0695","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11906-002-0041-2","article-title":"Reactive oxygen species: Roles in blood pressure and kidney function","volume":"4","author":"Wilcox","year":"2002","journal-title":"Current Hypertension Reports"},{"key":"10.1016\/bs.apha.2023.01.001_bb0700","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/HJH.0b013e32834aa786","article-title":"CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow","volume":"29","author":"Williams","year":"2011","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0705","doi-asserted-by":"crossref","first-page":"F1764","DOI":"10.1152\/ajprenal.90525.2008","article-title":"Transfer of the CYP4A region of chromosome 5 from Lewis to dahl S rats attenuates renal injury","volume":"295","author":"Williams","year":"2008","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181485","article-title":"The role of a FADS1 polymorphism in the association of fatty acid blood levels, BMI and blood pressure in young children-analyses based on path models","volume":"12","author":"Wolters","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.01.001_bb0715","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCRESAHA.108.179770","article-title":"Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging","volume":"104","author":"Wong","year":"2009","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0720","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41440-020-00548-3","article-title":"Sodium butyrate ameliorates deoxycorticosterone acetate\/salt-induced hypertension and renal damage by inhibiting the MR\/SGK1 pathway","volume":"44","author":"Wu","year":"2021","journal-title":"Hypertension Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e3182961659","article-title":"20-HETE and blood pressure regulation: Clinical implications","volume":"22","author":"Wu","year":"2014","journal-title":"Cardiology in Review"},{"key":"10.1016\/bs.apha.2023.01.001_bb0730","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1681\/ASN.2012070714","article-title":"Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase","volume":"24","author":"Wu","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/bs.apha.2023.01.001_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.730809","article-title":"The role of short-chain fatty acids of gut microbiota origin in hypertension","volume":"12","author":"Wu","year":"2021","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0740","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.115.305445","article-title":"Rare SNP rs12731181 in the miR-590-3p target site of the prostaglandin F2\u03b1 receptor gene confers risk for essential hypertension in the Han Chinese population","volume":"35","author":"Xiao","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0745","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138505","article-title":"Endothelial cell prostaglandin E2 receptor EP4 is essential for blood pressure homeostasis","volume":"5","author":"Xu","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/bs.apha.2023.01.001_bb0750","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/HYPERTENSIONAHA.122.18558","article-title":"Short-chain fatty acid receptors and blood pressure regulation: Council on hypertension mid-career award for research excellence 2021","volume":"79","author":"Xu","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0755","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.997403","article-title":"Eicosanoids in inflammation in the blood and the vessel","volume":"13","author":"Yamaguchi","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0760","doi-asserted-by":"crossref","first-page":"R1543","DOI":"10.1152\/ajpregu.00387.2010","article-title":"Postmenopausal hypertension: Role of 20-HETE","volume":"300","author":"Yanes","year":"2011","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0765","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coph.2014.12.011","article-title":"Crosstalk between (pro)renin receptor and COX-2 in the renal medulla during angiotensin II-induced hypertension","volume":"21","author":"Yang","year":"2015","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0770","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.chest.2016.10.058","article-title":"Mechanisms of vascular dysfunction in COPD and effects of a novel soluble epoxide hydrolase inhibitor in smokers","volume":"151","author":"Yang","year":"2017","journal-title":"Chest"},{"key":"10.1016\/bs.apha.2023.01.001_bb0775","doi-asserted-by":"crossref","first-page":"F819","DOI":"10.1152\/ajprenal.2000.279.5.F819","article-title":"Renin expression in COX-2-knockout mice on normal or low-salt diets","volume":"279","author":"Yang","year":"2000","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.001_bb0780","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1194\/jlr.M300183-JLR200","article-title":"12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels","volume":"44","author":"Yiu","year":"2003","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0785","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cccn.2004.04.028","article-title":"CYP2C9 allele variants in Chinese hypertension patients and healthy controls","volume":"348","author":"Yu","year":"2004","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.apha.2023.01.001_bb0790","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2010.09.004","article-title":"Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies","volume":"129","author":"Yuhki","year":"2011","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.001_bb0795","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1111\/jcmm.14684","article-title":"Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2\/PGE2 pathway via a HDAC5\/HDAC6-dependent mechanism","volume":"23","author":"Zhang","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/bs.apha.2023.01.001_bb896","first-page":"131","article-title":"Omega-3 polyunsaturated fatty acids improve endothelial function in humans at risk for atherosclerosis: A review. Prostaglandins & Other Lipid","volume":"134","author":"Zehr","year":"2018","journal-title":"Mediators"},{"key":"10.1016\/bs.apha.2023.01.001_bb0800","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/CIRCRESAHA.110.218404","article-title":"Nitro-oleic acid inhibits angiotensin II-induced hypertension","volume":"107","author":"Zhang","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0805","doi-asserted-by":"crossref","first-page":"35350","DOI":"10.1074\/jbc.M205738200","article-title":"Selective interleukin-12 synthesis defect in 12\/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia","volume":"277","author":"Zhao","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.01.001_bb0810","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/01.HYP.0000047877.36743.FA","article-title":"Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with salt-sensitive hypertension","volume":"41","author":"Zhao","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.001_bb0815","first-page":"1244","article-title":"Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage","volume":"15","author":"Zhao","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/bs.apha.2023.01.001_bb892","doi-asserted-by":"crossref","first-page":"101112","DOI":"10.1016\/j.plipres.2021.101112","article-title":"Phosphatidylserine-specific phospholipase A1: A friend or the devil in disguise","volume":"83","author":"Zhao","year":"2021","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/bs.apha.2023.01.001_bb0820","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1124\/jpet.105.095356","article-title":"Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats","volume":"317","author":"Zhou","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Advances in Pharmacology","Bioactive Lipid Mediators in Cardiopulmonary Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:21:57Z","timestamp":1753338117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358923000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323950572"],"references-count":177,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2023.01.001","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}